Description
The global microbiome market was valued at USD 1.7 billion in 2021, and it is estimated to reach USD 2.2 billion in 2028 with a CAGR of 7.2% during the forecast period of 2022-2028. Growing gastrointestinal disorders, technological advancements, rising investments in microbiome projects in developing countries, and the lucrative company of market players across the globe are elements responsible for the rapid expansion of the global microbiome market. The growing attention to women’s health drives the global human microbiome market. Market stakeholders expand their services arms by developing innovative and technologically progressive products to gain revenue benefits.
What is Microbiome?
The microbiome is a genetic element of different microorganisms such as bacteria, fungi, protozoa, and viruses present inside and on the human body. The microbiome consists of microbes that are both useful and potentially dangerous. Most are symbiotic, and some are pathogenic (promoting disease) in smaller numbers. In a healthy body, pathogenic and symbiotic microbiota coexist without issues. But dysbiosis occurs if a balance is disrupted—brought on by infectious illnesses, certain diets, or the prolonged use of antibiotics or other bacteria-destroying medications—stopping these normal interactions. As a result, the body may become more susceptible to disease.
